ETFA p.Thr178Arg
c.533C>G · rs140169311 · VCV203687
Computational evidence
| Protein change | ||
| AlphaMissense | 0.146 | likely benign |
|---|---|---|
| REVEL | 0.319 | indeterminate |
| SaProt | LLR -9.42 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 4.6 | GERP 1.9, phastCons 1 |
| Regional constraint | o/e 0.86 | unconstrained · MANE · 95 kb · p 0.0051 · regional, not allelic |
| Overall | ||
| CADD | 19.17 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 0.283% | 354 |
| European (non-Finnish)grpmax | 0.0505% | 1,982 |
| Remaining individualsnot grpmax-eligible | 0.0224% | 4,461 |
| Admixed American | 0.0183% | 5,453 |
| Middle Eastern | 0.0164% | 6,084 |
| African / African-American | 0.00534% | 18,726 |
| Ashkenazi Jewishnot grpmax-eligible | 0.00338% | 29,592 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ETFA
- Protein
- p.Thr178Arg
- Coding
- c.533C>G
- MANE Select
- NM_000126
- dbSNP
- rs140169311
- Type
- single nucleotide variant
- Location
- chr15:76286400 (GRCh38)
- Gene constraint
- LOEUF 1.166 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 94.00 · 4 PDB
- Residue 178
- the 'domain i' region; a β-strand
Disease context
multiple acyl-CoA dehydrogenase deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Multiple acyl-CoA dehydrogenase deficiency (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- All ages
- Prevalence
- 1-9 / 1 000 000 (United States)
Similar variants
- ETFA c.186+1G>A Likely pathogenic ★★ same condition
- ETFA c.39+1G>A Likely pathogenic ★★ same condition
- ETFA c.451+1G>A Likely pathogenic ★★ same condition
- ETFA c.452-2A>G Likely pathogenic ★★ same condition
- ETFA c.664+1G>A Likely pathogenic ★★ same condition
- ETFA c.665-1G>A Likely pathogenic ★★ same condition
- ETFA p.Arg122Lys Likely pathogenic ★★ same condition
- ETFA p.Arg18Ter Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/etfa-p-thr178arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown